These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16922652)

  • 21. Reactive metabolites in early drug development: predictive in vitro tools.
    Pelkonen O; Pasanen M; Tolonen A; Koskinen M; Hakkola J; Abass K; Laine J; Hakkinen M; Juvonen R; Auriola S; Storvik M; Huuskonen P; Rousu T; Rahikkala M
    Curr Med Chem; 2015; 22(4):538-50. PubMed ID: 25312212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based drug metabolism predictions for drug design.
    Sun H; Scott DO
    Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From known knowns to known unknowns: predicting in vivo drug metabolites.
    Pelkonen O; Tolonen A; Korjamo T; Turpeinen M; Raunio H
    Bioanalysis; 2009 May; 1(2):393-414. PubMed ID: 21083174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
    Baumann A; Karst U
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
    Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
    Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose Predictions for Drug Design.
    Maurer TS; Smith D; Beaumont K; Di L
    J Med Chem; 2020 Jun; 63(12):6423-6435. PubMed ID: 31913040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition-based metabolic drug-drug interactions: predictions from in vitro data.
    Yao C; Levy RH
    J Pharm Sci; 2002 Sep; 91(9):1923-35. PubMed ID: 12210040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
    Roberts SA
    Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting circulating human metabolites: how good are we?
    Anderson S; Luffer-Atlas D; Knadler MP
    Chem Res Toxicol; 2009 Feb; 22(2):243-56. PubMed ID: 19138063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
    Pearce RG; Setzer RW; Davis JL; Wambaugh JF
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cyanide-trapped methylated metabonates formed during reactive drug metabolite screening in vitro.
    Rousu T; Tolonen A
    Rapid Commun Mass Spectrom; 2011 May; 25(10):1382-90. PubMed ID: 21504003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting drug metabolism: experiment and/or computation?
    Kirchmair J; Göller AH; Lang D; Kunze J; Testa B; Wilson ID; Glen RC; Schneider G
    Nat Rev Drug Discov; 2015 Jun; 14(6):387-404. PubMed ID: 25907346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative drug interactions prediction system (Q-DIPS): a computer-based prediction and management support system for drug metabolism interactions.
    Bonnabry P; Sievering J; Leemann T; Dayer P
    Eur J Clin Pharmacol; 1999 Jul; 55(5):341-7. PubMed ID: 10456482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments of in silico predictions of oral bioavailability.
    Zhu J; Wang J; Yu H; Li Y; Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):362-74. PubMed ID: 21470180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.